What a brutal six months it’s been for Omnicell. The stock has dropped 24.6% and now trades at $32.45, rattling many shareholders. This was partly driven by its softer quarterly results and may ...

But really big losses can really drag down an overall portfolio. So spare a thought for the long term shareholders of Omnicell, Inc. (NASDAQ:OMCL); the share price is down a whopping 75% in the ...

Omnicell, Inc. OMCL has witnessed strong momentum in the past year. Shares of the company have risen 41.6% against a 11.3% decline of the industry during the same time frame. The S&P 500 composite ...

Omnicell OMCL underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light ...

Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have earned an average recommendation of “Hold” from the six research firms that are covering the stock, MarketBeat reports.

Omnicell (NASDAQ:OMCL – Get Free Report) had its price objective cut by stock analysts at JPMorgan Chase & Co. from $44.00 to $36.00 in a research report issued to clients and investors on ...

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and ...

But really big losses can really drag down an overall portfolio. So spare a thought for the long term shareholders of Omnicell, Inc. (NASDAQ:OMCL); the share price is down a whopping 75% in the last ...